IS

ISOTIS INC

  • CIK: 0001380180
  • EIN: 20-5825634
  • Business address: 2 GOODYEAR, IRVINE, California, 92618

Information

  • Mailing address
    2 GOODYEAR, IRVINE, Delaware, 92618
  • Phone
    9495958710
  • State location
    California
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
  • Filings
    N/A

About ISOTIS INC

ISOTIS INC (CIK: 0001380180) is an American company incorporated in the state of California. Head office is located at 2 GOODYEAR, IRVINE, California, 92618. Work in the industry 8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH. ISOTIS INC is a public company and trade via Over-The-Counter (OTC).

Ownership

Owner Filings Transaction Date Type of Owner
Abraham James 0001397731 Apr-25-2007 officer: Senior VP Sales
GILL DAVID N 0001106519 Jan-26-2007 director
KOLLIN DANIEL W 0001220127 Jan-26-2007 director
BOYAN BARBARA D 0001283878 Jan-26-2007 director
Elliott Darrell J 0001368735 Jan-26-2007 director
BROUWER AART 0001387205 Jan-26-2007 director
TROTMAN JAMES 0001387209 Jan-26-2007 director
REU GENE B 0001387210 Jan-26-2007 officer: VP Operations
LILJESTRAND KATHRYN 0001387358 Jan-26-2007 officer: VP Marketing
MOROCCO ROBERT J 0001387359 Jan-26-2007 officer: CFO/Sr. VP. Treas. and Sec.
WOLTERS PIETER 0001387360 Jan-26-2007 director, officer: President and CEO
POSER JAMES W 0001387601 Jan-26-2007 officer: Sr. VP R&D, CTO
DONZE ALAN 0001387657 Jan-26-2007 officer: VP Sales
HART JAMES 0001387744 Jan-26-2007 director
KAY JOHN F 0001387745 Jan-26-2007 officer: Chief Scientific Officer
Morell Karon 0001387979 Jan-26-2007 officer: VP Reg & Quality

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ISOTIS INC

Filings Format Description Filed/Effective File/Film Number
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001209191-07-060535 ( Act) Size: 5 KB		 Oct-30-2007

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001209191-07-060534 ( Act) Size: 5 KB		 Oct-30-2007

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001209191-07-060533 ( Act) Size: 5 KB		 Oct-30-2007

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001209191-07-060531 ( Act) Size: 5 KB		 Oct-30-2007

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001209191-07-060527 ( Act) Size: 6 KB		 Oct-30-2007

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001209191-07-060524 ( Act) Size: 6 KB		 Oct-30-2007

15-12B Document

Notice of termination of registration of a class of securities under Section 12(b)

Acc-no: 0000950134-07-022192 (34 Act) Size: 8 KB		 Oct-30-2007

001-33272

071197879
25-NSE Document Acc-no: 0001354457-07-000332 (34 Act) Size: 3 KB Oct-29-2007

001-33272

071197345
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0000950137-07-016109 (34 Act) Size: 17 KB		 Oct-29-2007

001-33272

071195785
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0000950137-07-016058 (34 Act) Size: 16 KB		 Oct-26-2007

001-33272

071193542
8-K Document

Current report filing

Acc-no: 0000950134-07-021943 (34 Act) Size: 30 KB		 Oct-25-2007

001-33272

071189444
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0000950137-07-015932 (34 Act) Size: 24 KB		 Oct-24-2007

001-33272

071187787
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0000892569-07-001311 (34 Act) Size: 20 KB		 Oct-19-2007

001-33272

071181832
SC 13G Document

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001204459-07-001568 (34 Act) Size: 74 KB		 Oct-17-2007

005-83200

071176946
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0000950137-07-015645 (34 Act) Size: 19 KB		 Oct-17-2007

001-33272

071175934
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0000950137-07-015599 (34 Act) Size: 29 KB		 Oct-16-2007

001-33272

071173924
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0000950137-07-015598 (34 Act) Size: 18 KB		 Oct-16-2007

001-33272

071173907
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0000892569-07-001294 (34 Act) Size: 32 KB		 Oct-12-2007

001-33272

071169940
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0000892569-07-001292 (34 Act) Size: 16 KB		 Oct-12-2007

001-33272

071168123
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0000892569-07-001265 (34 Act) Size: 20 KB		 Oct-05-2007

001-33272

071157742

Recent 20 filings. View all ISOTIS INC filings

Reviews

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Frequently Asked Questions

Tags:

  • ISOTIS INC overview
  • ISOTIS INC job
  • ISOTIS INC stock
  • ISOTIS INC ownership
  • ISOTIS INC CEO
  • ISOTIS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Zymergen Inc.
Update: Aug 26, 2022
XXSYS TECHNOLOGIES INC /CA
Update: Aug 25, 2022
WHISTLER INC
Update: Aug 25, 2022
WCG Clinical, Inc.
Update: Aug 25, 2022
Viventia Biotech Inc.
Update: Aug 24, 2022
VIACELL INC
Update: Aug 24, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 2113 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 1070 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 4093 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 2735 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 2465 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 3165 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 4308 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 1829 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 1502 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by